Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...
Chase Markel, a University of Wyoming Ph.D. student from Wheatland, is harnessing artificial intelligence (AI) to transform ...
For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was ...
PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...
It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. -- Surrogate assays are a breakthrough for AI model training. 1910 ...
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...
Steffini Stalos, DO, FCAP, is a pathology and lab medicine physician. She is also the chief medical officer of the lab consultancy firm Blood Associates, LLC. Mean corpuscular hemoglobin concentration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback